Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Hormel Recalls Over 256,000 Pounds of Canned Beef Stew

FRIDAY, May 30, 2025 Hormel Foods is recalling more than 256,000 pounds of its Dinty Moore Beef Stew amid reports that wood fragments were found in some cans, a

ASCO: AI Training Improves Accuracy of HER2 Immunohistochemistry Scoring

Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scori

ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC

For patients with BRAF V600E-mutated metastatic colorectal cancer, progression-free and overall survival are significantly longer with encorafenib plus cetuxima

16 Updates, Four New Recommendations Issued for Management of Pediatric VTE

In clinical guidelines issued by the American Society of Hematology and the International Society on Thrombosis and Haemostasis, and published online May 27 in

Substantial and Increasing Burden of Skin Cancer Seen in Older Adults

Older adults have a substantial and increasing burden of skin cancer, according to a study published online May 21 in JAMA Dermatology.Ruiyao Wang, M.D., from T

Longer In-Bed Time Linked to Small Vessel Disease Burden in TIA/Mild Stroke

For adult patients with transient ischemic attack (TIA) mild stroke, disturbed sleep is associated with greater cerebral small vessel disease (SVD) burden and w

FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice

FRIDAY, May 30, 2025 Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine causing sharp criticism from do

Teva Celiac Disease Candidate TEV-53408 Granted Fast Track Designation by US FDA

Teva Pharmaceutical Industries, Ltd. (NYSE and TASE TEVA) today announced that the US Food and Drug Administration (FDA) granted Fast Track designation for inve

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

Rocket Pharmaceuticals, Inc. (NASDAQ RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare

Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST - Modifier Gene Therapy for the Treatment of Stargardt Disease

Ocugen, Inc. (Ocugen or the Company) (NASDAQ OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the United

Popular Keywords